The Impact of Soft Contact Lens Attributes on Symptoms Associated With Digital Eye Strain in Symptomatic Soft Contact Lens Wearers

December 19, 2019 updated by: Pete Kollbaum, OD, PhD
Despite its prevalence, the ocular causes of eye fatigue or unknown and may be related to the cornea/contact lens surface, the accommodative system, the convergence system, overall postural/muscle fatigue, or a combination of these or other causes. The current study aims to systematically investigate the incremental benefits in ameliorating eye fatigue.

Study Overview

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Bloomington, Indiana, United States, 47405
        • Indiana University Clinical Optics Research Lab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 31 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Self-reported "eye fatigue" at least once per week attributable to digital device use with baseline.
  2. Uses a digital device (phone, tablet, computer, etc) at least 4 hours per day
  3. Mobile digital device with active data and text plan, able to receive email and text messages
  4. Habitual 2-week or monthly silicone single vision hydrogel soft contact lens use; habitually wearing lenses for 6 or more hours per day for 5 or more days per week for the past 30 days
  5. Habitual soft contact lens prescription optimized over-refraction within ±0.25 D
  6. 18-35 years of age
  7. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  8. Vertex corrected refractive cylinder must be -0.75 or less.
  9. Visual acuity best correctable to 20/25 or better for each eye
  10. The subject must read and sign the Informed Consent form.

Exclusion Criteria:

  1. A habitual wearer of any of the test lenses
  2. Any active conditions that may prevent soft contact lens wear.
  3. Any doctor diagnosed, self-reported ocular surface disease or dry eye requiring regular, ongoing treatment
  4. Any doctor diagnosed, self-reported accommodative or binocular vision issues
  5. History of issues of eye alignment or binocularity by self-report

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Multifocal Optics first, then Single Vision Optics
First Intervention (1 week) Second Intervention (1 week)
This contact lens has optics to aid the accommodative and convergence systems
This contact lens has standard single vision optics
Other: Single Vision Optics first, then Multifocal Optics
First Intervention (1 week) Second Intervention (1 week)
This contact lens has optics to aid the accommodative and convergence systems
This contact lens has standard single vision optics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject Reported Eye Fatigue
Time Frame: 1 week
Subjective Rating of Eye Fatigue, response to question "How would you rate your overall eye fatigue/tiredness?" on a 0-100 slider visual analog scale, where 0 represents 'Not Noticeable' and 100 represents 'Very Noticeable', with the numerical representation of their visual analog selection displayed to the right of the slider scale. Score reported is rating as described above.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2018

Primary Completion (Actual)

November 2, 2018

Study Completion (Actual)

November 2, 2018

Study Registration Dates

First Submitted

April 26, 2018

First Submitted That Met QC Criteria

July 2, 2018

First Posted (Actual)

July 13, 2018

Study Record Updates

Last Update Posted (Actual)

January 7, 2020

Last Update Submitted That Met QC Criteria

December 19, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Kollbaum001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Contact lens with Multifocal Optics

Subscribe